Abstract
With the advent of more successful chemotherapies, the number of cancer survivors continues to increase. Unfortunately, many of these patients will exhibit long-term sequelae from their treatments, including serious cognitive deficits that impair daily function. In this issue of Cell, Gibson et al. (2019) demonstrate that chemotherapy-related cognitive impairment is orchestrated by microglia.
Original language | English |
---|---|
Pages (from-to) | 2-4 |
Number of pages | 3 |
Journal | Cell |
Volume | 176 |
Issue number | 1-2 |
DOIs | |
State | Published - Jan 10 2019 |